Article
Prospects and challenges of circulating tumor DNA in precision medicine of hepatocellular carcinoma.
Clinical and experimental medicine - 1 Aug 2020
Weng Jialei, Atyah Manar, Zhou Chenhao, Ren Ning
Abstract excerpt
The growing role of precision medicine in hepatocellular carcinoma (HCC) is expected to ameliorate the poor prognosis and high mortality of this highly malignant disease; however, it is faced with challenges such as the low frequency of tissue biopsy. Hence, attention is turning to the circulating tumor DNA (ctDNA), an important component of liquid biopsy. Obtaining molecular information about cancer from blood...
Topics
Join the communities discussing this publication.